The recommended dosage and schedule in combination with chlorambucil is:
The recommended dosage and schedule in combination with fludarabine and cyclophosphamide is:
The recommended dosage and schedule as single-agent extended treatment in CLL is:
The recommended dosage and schedule is 12 doses administered as follows:
Administer ARZERRA in an environment where facilities to adequately monitor and treat infusion reactions are available [see WARNINGS AND PRECAUTIONS].
Prepare all doses in 1,000 mL of 0.9% Sodium Chloride Injection, USP [see Preparation And Administration].
In the absence of an infusion-related adverse event, the rate of infusion may be increased every 30 minutes (Table 1). Do not exceed the infusion rates in Table 1.
Table 1. Infusion Rates for ARZERRA in Previously Untreated CLL, Relapsed CLL, and Extended Treatment in CLL 
In the absence of an infusion-related adverse event, the rate of infusion may be increased every 30 minutes (Table 2). Do not exceed the infusion rates in Table 2.
Table 2. Infusion Rates for ARZERRA in Refractory CLL 
Patients should receive all of the following premedication agents 30 minutes to 2 hours prior to each infusion of ARZERRA. See Table 3 for pre-medication schedule prior to each infusion.
Table 3. Premedication Schedule for ARZERRA 
